Effect of amphotericin B associated with a lipid emulsion on the oxidative burst of human polymorphonuclear leukocytes

General Pharmacology

Volumn 28, Issue 2, 1997, Pages 203-207

  Marzzullo, Luciane ^a   Souza, Liliete Canes ^a   Campa, Ana ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

amphotericin B; polymorphonuclear leukocyte oxidative burst; triglyceride rich emulsion

Indexed keywords

AMPHOTERICIN B; CHOLESTEROL; LIPID EMULSION; LUMINOL; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHATIDYLCHOLINE; TRIACYLGLYCEROL; TRIOLEIN; ZYMOSAN;

ARTICLE; CELL VIABILITY; CHEMOLUMINESCENCE; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; MYCOSIS; NEUTROPHIL; PRIORITY JOURNAL; RESPIRATORY BURST;

AMPHOTERICIN B; ANTI-BACTERIAL AGENTS; ANTIBIOTICS, ANTIFUNGAL; CELL SURVIVAL; CHEMILUMINESCENT MEASUREMENTS; EMULSIONS; HUMANS; KINETICS; NEUTROPHILS; RESPIRATORY BURST; TETRADECANOYLPHORBOL ACETATE; TRIGLYCERIDES; ZYMOSAN;

EID: 0031030871     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(96)00220-0     Document Type: Article

References (39)

1. Allen R. C. (1986) Phagocyte leukocyte oxygenation activity and chemiluminescence: a kinetic approach to analysis. Methods Enzymol. 133, 449-493.
2. Appelberg R., Castro A. G. and Silva M. T. (1994) Neutrophils as effector cells of T-cell-mediated, acquired immunity in murine listeriosis. Immunology 83, 302-307.
3. Badwey J. A., Curnutte J. T. and Karnovsky M. L. (1981) cis-Polyunsaturated fatty acids induce high levels of superoxide production by human neutrophils. J. Biol. Chem. 256, 12640-12643.
4. Bellinati-Pires R., Waitzberg D. L., Salgado M. M. and Carneiro-Sampaio M. M. S. (1993) Functional alterations of human neutrophils by medium-chain triglyceride emulsions: evaluation of phagocytosis, bacterial killing, and oxidative activity. J. Leukocyte Biol. 53, 404-410.
5. Bennett J. E. (1985) Antifungal agents. In: Principles and Practice of Infectious Disease, (Edited by Mandell G. L., Douglas R. G. and Bennet J. E.), pp. 263-270. 2nd edn. Wiley, New York.
6. Bjorksten B., Ray C. and Quie P. G. (1976) Inhibition of human neutrophil chemotaxis and chemoluminescence by amphotericin B. Infect. Immunol. 14, 315-317.
7. Bolard J. (1986) How do the polyene macrolide antibiotics affect the cellular membrane properties? Biochim. Biophys. Acta 864, 257-304.
8. Bolard J., Legrand H. F. and Cybulska B. (1991) One-sided action of amphotericin B on cholesterol-containing membranes is determined by its self-association in the medium. Biochemistry 30, 5707-5715.
9. Brajtburg J., Elberg S., Bolard J., Kobayashi G. S., Levy R. A. and Ostlund R. E. (1984) Interactions of plasma proteins and lipoproteins with amphotericin B. J. Infect. Dis. 149, 986-997.
10. Cassatella M. A., Meda L., Gasperini S., D'Andrea A. and Trinchieri G. (1995) Interleukin-12 production by human polymorphonuclear leukocytes. Eur. J. Immunol. 25, 1-25.
11. Chopra R., Blair S., Strang J., Cervi P., Patterson K. G. and Goldstone A. H. (1991) Liposomal amphotericin B (AmBisome) in the treatment of fungal infections in neutropenic patients. J. Antimicrob. Chemother. 28, 93-104.
12. Davies S. S., Washington C., West P., Illum L., Liversidge G. and Sterson L. (1987) Lipid emulsions as drug delivery systems. Ann. N.Y. Acad. Sci. 507, 75-88.
13. Hardie W. D., Wheeler A. P., Wright P. W., Swindell B. B. and Bernard G. R. (1992) Effect of cyclooxygenase inhibition on amphotericin B-induced lung injury in awake sheep. J. Infect. Dis. 166, 134-138.
14. Hardy S. J., Robinson B. S., Poulos R., Harvey D. P., Ferrante A. and Murray A. W. (1991) The neutrophil respiration burst. Eur. J. Biochem. 198, 801-806.
15. Heyworth P. G. and Badwey J. A. (1990) Protein phosphorylation associated with the stimulation of neutrophils. Modulation of superoxide production by protein kinase C and calcium. J. Bioenerg. Biomembr. 22, 1-26.
16. Illum L., West P., Washington C. and Davis S. S. (1989) The effect of stabilising agents on the organ distribution of lipid emulsions. Int. J. Pharmacol. 54, 41-49.
17. Johnson O. L., Washington C., Davis S. S., and Schaupp K. (1989) The destabilization of parenteral feeding emulsions by heparin. Int. J. Pharm. 53, 237-240.
18. Joly V., Saint-Julien L., Carbon C. and Yeni P. (1990) Interactions of free and liposomal amphotericin B with renal proximal tubular cells in primary culture. J. Pharmacol. Experim. Therap. 255, 17-22.
19. Juliano R. L., Grant C. W. M., Barber K. R. and Kalp M. A. (1987) Mechanism of the selective toxicity of amphotericin B incorporated into liposomes. Mol. Pharmacol. 31, 1-11.
20. Jullien S., Capuozzo E., Salerno C. and Crifo C. (1991) Effects of polyene antibiotics on the activation of human polymorphonuclear leukocytes. Biochem. Pharmacol. 41, 2037-2040.
21. Kamp H. H., Wirtz K. W. A., Baer P. R., Slotboom A. S., Rosenthal A. F. and Paltauf F. (1977) Specificity of the phosphatidylcholine exchange protein from bovine liver. Biochemistry 16, 1310-1316.
22. Khoo S. H., Bond J. and Denning D. W. (1994) Administering amphotericin B - a practical approach. J. Antimicrob. Chemother. 33, 203-213.
23. Kirsh R., Goldstein R., Tarloff J., Parris D., Hook J. and Hanna N. (1988) An emulsion formulation of amphotericin B improves the therapeutic index when treating systemic murine candidiasis. J. Infec. Dis. 158, 1065-1070.
24. Lohr K. M. and Snyderman R. (1982) Amphotericin B alters the affinity of the oligopeptide chemotatic factor receptor on human polymorphonuclear leukocytes. J. Immunol. 129, 1594-1599.
25. Lopez-Berestein G., Mehta R., Hopfer R. L., Mills K., Kasi L. and Mehta K. (1983) Treatment and prophylaxis of disseminated infection due to Candida albicans in mice with liposome-encapsulated amphotericin B. J. Infect. Dis. 147, 939-945.
26. Maranhão R. C., Tercyak A. M. and Redgrave T. G. (1986) Effects of cholesterol on the metabolism of protein-free emulsion models of lipoproteins. Biochim. Biophys. Acta 875, 247-255.
27. Warmer D. J., Fields B. T., France G. L. and Steele R. W. (1981) Ketoconazole, amphotericin B, and amphotericin B methyl methyl ester: comparative in vitro and in vivo toxicological effects on neutrophil function. Antimicrob. Agents Chemother. 20, 660-665.
28. Marzzullo L., Oliveira E. P., Souza L. C. and Campa A. (1995) Toxicity of amphotericin B in analbuminemic rats. Environm. Toxicol. Pharmacol., (in press).
29. McGrath K., Bertram J. F., Houghton S., Boothman J., Manderson J. A. and Minchinton R. (1992) Amphotericin B-induced injury in stored human platelets. Transfusion 32, 46-50.
30. Mehta R. T., Lopez-Berestein G., Hopfer R., Mills K. and Juliano R. L. (1984) Liposomal amphotericin B is toxic to fungal cells but not to mammalian cells. Biochim. Biophys. Acta 770, 230-234.
31. Patterson T. F. and Andriole V. T. (1989) The role of liposomal amphotericin B in the treatment of systemic fungal infections. Eur. J. Cancer Clin. Oncol. 25, S63-S68.
32. Patterson T. F., Mimter P., Ryan J. L. and Andriole V. T. (1988) Effect of immunosuppression and amphotericin B on aspergillus antigenemia in an experimental model. J. Infect. Dis. 158, 415-422.
33. Proffitt R. T., Satorius A., Chiang S-M., Sullivan L. and Alder-Moore J. P. (1991) Pharmacology and toxicology of a liposomal formulation of amphotericin B (AmBisome) in rodents. J. Antimicrob. Chemother. 28, 49-61.
34. Ringden O., Meunier F., Tollemar J., Ricci P., Tura S. and Kruse E. (1991) Efficacy of amphotericin B encapsulated in liposomes (AmBisome) in the treatment of invasive fungal infections in immunocompromised patients. J. Antimicrob. Chemother. 28, 73-82.
35. Robins A. P., Arain I., Phuangsab A., Holian O., Roccaforte P. and Barrett J. A. (1989) Intravenous fat emulusion acutely suppresses neutrophil chemiluminescence. J. Parenter. Enteral Nutr. 13, 608-613.
36. Souza L. C., Maranhão R. C., Schreier S. and Campa A. (1993) In-vitro and in-vivo studies of the decrease of amphotericin B toxicity upon association with a triglyceride-rich emulsion. J. Antimicrob. Chemother. 32, 123-132.
37. Supapidhayakul S-R., Kizlaitis L. R. and Andersen B. R. (1981) Stimulation of human and canine neutrophil metabolism by amphotericin B. Antimicrob. Agents Chemother. 19, 284-289.
38. Uhlinger D. J., Burnham D. N., Mullins R. E. et al (1991) Functional differences in human neutrophils isolated pre- and post-prandially. FEBS Lett. 286, 28-32.
39. Washington C., Taylor S. J. and Davis S. S. (1988) The structure of colloidal formulations of amphotericin B. Int. J. Pharm. 46, 25-30.